Literature DB >> 23877645

Dementia: Mild cognitive impairment--amyloid and beyond.

Philip Scheltens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23877645     DOI： 10.1038/nrneurol.2013.147

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 2.  Clinical practice. Mild cognitive impairment.

Authors:  Ronald C Petersen
Journal:  N Engl J Med       Date:  2011-06-09       Impact factor: 91.245

3.  Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints.

Authors:  Argonde C van Harten; Pieter Jelle Visser; Yolande A L Pijnenburg; Charlotte E Teunissen; Marinus A Blankenstein; Philip Scheltens; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2012-12-08       Impact factor: 21.566

4.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

5.  Injury markers predict time to dementia in subjects with MCI and amyloid pathology.

Authors:  Ineke A van Rossum; Stephanie J B Vos; Leah Burns; Dirk L Knol; Philip Scheltens; Hilkka Soininen; Lars-Olof Wahlund; Harald Hampel; Magda Tsolaki; Lennart Minthon; Gilbert L'italien; Wiesje M van der Flier; Charlotte E Teunissen; Kaj Blennow; Frederik Barkhof; Daniel Rueckert; Robin Wolz; Frans Verhey; Pieter Jelle Visser
Journal:  Neurology       Date:  2012-09-26       Impact factor: 9.910

6.  Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.

Authors:  Stephanie J B Vos; Ineke A van Rossum; Frans Verhey; Dirk L Knol; Hilkka Soininen; Lars-Olof Wahlund; Harald Hampel; Magda Tsolaki; Lennart Minthon; Giovanni B Frisoni; Lutz Froelich; Flavio Nobili; Wiesje van der Flier; Kaj Blennow; Robin Wolz; Philip Scheltens; Pieter Jelle Visser
Journal:  Neurology       Date:  2013-02-27       Impact factor: 9.910

7.  Mild cognitive impairment due to Alzheimer disease in the community.

Authors:  Ronald C Petersen; Paul Aisen; Bradley F Boeve; Yonas E Geda; Robert J Ivnik; David S Knopman; Michelle Mielke; Vernon S Pankratz; Rosebud Roberts; Walter A Rocca; Stephen Weigand; Michael Weiner; Heather Wiste; Clifford R Jack
Journal:  Ann Neurol       Date:  2013-08       Impact factor: 10.422

8.  Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease.

Authors:  Pieter Jelle Visser; Stephanie Vos; Ineke van Rossum; Philip Scheltens
Journal:  Alzheimers Dement       Date:  2012-11       Impact factor: 21.566

9.  Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease.

Authors:  Annapaola Prestia; Anna Caroli; Wiesje M van der Flier; Rik Ossenkoppele; Bart Van Berckel; Frederik Barkhof; Charlotte E Teunissen; Anders E Wall; Stephen F Carter; Michael Schöll; Il Han Choo; Agneta Nordberg; Philip Scheltens; Giovanni B Frisoni
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

10.  International Work Group criteria for the diagnosis of Alzheimer disease.

Authors:  Jeffrey L Cummings; Bruno Dubois; José L Molinuevo; Philip Scheltens
Journal:  Med Clin North Am       Date:  2013-02-16       Impact factor: 5.456
  10 in total
  1 in total

1.  The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.

Authors:  Gøril Rolfseng Grøntvedt; Camilla Lauridsen; Guro Berge; Linda R White; Øyvind Salvesen; Geir Bråthen; Sigrid Botne Sando
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.